Healthcare communications and marketing news and information

I thought readers of this blog might be interested in an interview series I am running on race and medicine on my other blog, Envisioning 2.0.  To date, I have run three interviews in this series.  It is titled, "Conversations About Race-Based Medicine." 

In upcoming weeks, I will be publishing a conversation I had with NitroMed on this topic.  NitroMed makes BiDil, the first medication ever approved for the treatment of a specific racial group: self-identified African Americans with heart failure. 

Click here to read a press release on this series.  Click here to read the interviews.  I will publish the final four conversations on Envisioning 2.0 in April and May.